Literature DB >> 4629438

The effect of azathioprine on gammaglobulin synthesis in man.

J Levy, E V Barnett, N S MacDonald, J R Klinenberg, C M Pearson.   

Abstract

The effect of azathioprine therapy on gammaglobulin synthesis was evaluated in nine patients with rheumatic disorders. The rates of synthesis of IgG and IgM were calculated before and after 4 months of azathioprine treatment using turnover studies of radioiodinated gammaglobulins. The synthesis of IgG decreased 33.4% of the initial IgG synthetic rate. Seven of nine patients showed reductions of IgG synthesis ranging from 16.8 to 74.1%. IgM production decreased from 24.5 to 74.2% in eight of nine patients with a mean reduction of 40.9%. Studies before and after a control period of 4 months of placebo in six patients revealed a mean increase in IgG and IgM synthesis. Serum immunoglobulin concentrations after 4 months of azathioprine treatment were not consistently reduced and did not parallel changes in immunoglobulin synthesis. Reduced gammaglobulin synthesis may play a role in the therapeutic action of this and other "immunosuppressive" drugs.

Entities:  

Mesh:

Substances:

Year:  1972        PMID: 4629438      PMCID: PMC292386          DOI: 10.1172/JCI107031

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  36 in total

1.  INHIBITION OF IMMEDIATE AND DELAYED HYPERSENSITIVITY IN THE RABBIT BY 6-MERCAPTOPURINE.

Authors:  Y BOREL; R SCHWARTZ
Journal:  J Immunol       Date:  1964-05       Impact factor: 5.422

2.  GAMMA-2, GAMMA-1A AND GAMMA-1M ANTINUCLEAR FACTORS IN HUMAN SERA.

Authors:  E V BARNETT; J J CONDEMI; J P LEDDY; J H VAUGHAN
Journal:  J Clin Invest       Date:  1964-06       Impact factor: 14.808

3.  FACTORS CONTROLLING SERUM GAMMA-GLOBULIN CONCENTRATION.

Authors:  J L FAHEY; A G ROBINSON
Journal:  J Exp Med       Date:  1963-11-01       Impact factor: 14.307

Review 4.  AUTOANTIBODIES AND DISEASE.

Authors:  H G KUNKEL; E M TAN
Journal:  Adv Immunol       Date:  1964       Impact factor: 3.543

5.  The latex fixation test. I. Application to the serologic diagnosis of rheumatoid arthritis.

Authors:  C M PLOTZ; J M SINGER
Journal:  Am J Med       Date:  1956-12       Impact factor: 4.965

6.  Suppression of IgM and IgG synthesis in young rabbits by 6-methyl mercaptopurine treatment.

Authors:  H G Herrod; M Myers; K S Self; M D Cooper
Journal:  J Lab Clin Med       Date:  1970-07

7.  In vitro evaluation of immunosuppressive drugs.

Authors:  J F Bach; M Dardenne; C Fournier
Journal:  Nature       Date:  1969-06-07       Impact factor: 49.962

8.  IMMUNOLOGIC STUDIES IN HUMAN ORGAN TRANSPLANTATION. I. OBSERVATION AND CHARACTERIZATION OF SUPPRESSED CUTANEOUS REACTIVITY IN UREMIA.

Authors:  C H KIRKPATRICK; W E WILSON; D W TALMAGE
Journal:  J Exp Med       Date:  1964-05-01       Impact factor: 14.307

9.  Hypercatabolism of normal IgG; an unexplained immunoglobulin abnormality in the connective tissue diseases.

Authors:  R D Wochner
Journal:  J Clin Invest       Date:  1970-03       Impact factor: 14.808

10.  Studies on the anti-inflammatory action of 6-mercaptopurine.

Authors:  E R Hurd; M Ziff
Journal:  J Exp Med       Date:  1968-10-01       Impact factor: 14.307

View more
  16 in total

1.  [Immunglobulin levels after kidney transplantation and during rejection crisis (author's transl)].

Authors:  R Oppolzer; K Schieler; C Leithner; W Pinggera; A Wolf; H Stummvoll; F Singer
Journal:  Klin Wochenschr       Date:  1975-09-01

Review 2.  Combination therapy for autoimmune diseases: the rheumatoid arthritis model.

Authors:  N Fathy; D E Furst
Journal:  Springer Semin Immunopathol       Date:  2001

3.  Metabolism of autologous and homologous IgG in rheumatoid arthritis.

Authors:  M A Catalano; E H Krick; D H De Heer; R M Nakamura; A N Theofilopoulos; J H Vaughan
Journal:  J Clin Invest       Date:  1977-08       Impact factor: 14.808

4.  Clinical and biochemical assessment of anti-inflammatory substances.

Authors:  P Franchimont
Journal:  Agents Actions       Date:  1976-02

5.  [The variation of 16 serum protein fractions following renal transplantation (author's transl)].

Authors:  C Marone; W Flury; A Montandon; H Keller
Journal:  Klin Wochenschr       Date:  1978-07-01

Review 6.  Treatment of vasculitis.

Authors:  H G Taylor; A Samanta
Journal:  Br J Clin Pharmacol       Date:  1993-02       Impact factor: 4.335

7.  Immune response in patients with autoimmune thrombocytopenia and autoimmune haemolytic anaemia receiving azathioprine.

Authors:  K M Goebel; F D Goebel; W D Gassel; K Mueller
Journal:  Klin Wochenschr       Date:  1974-10-01

8.  Serum biochemistry in relation to the action of azathioprine in rheumatoid arthritis.

Authors:  J S Dixon; H A Bird; N G Sitton; M E Pickup; P A Leatham; V Wright
Journal:  Agents Actions       Date:  1983-06

9.  Disparity between clinical and immune responses in a controlled trial of azathioprine in rheumatoid arthritis.

Authors:  K M GOEBEL; R Janzen; K Joseph; U Börngen
Journal:  Eur J Clin Pharmacol       Date:  1976-03-22       Impact factor: 2.953

Review 10.  Disease-modifying antirheumatic drugs. Potential effects in older patients.

Authors:  G Gardner; D E Furst
Journal:  Drugs Aging       Date:  1995-12       Impact factor: 3.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.